0001781983-25-000003.txt : 20251229 0001781983-25-000003.hdr.sgml : 20251229 20251223174446 ACCESSION NUMBER: 0001781983-25-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251229 DATE AS OF CHANGE: 20251223 EFFECTIVENESS DATE: 20251229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aprea Therapeutics, Inc. CENTRAL INDEX KEY: 0001781983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-568049 FILM NUMBER: 251601931 BUSINESS ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 BUSINESS PHONE: 215-948-4119 MAIL ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 D 1 primary_doc.xml X0708 D LIVE 0001781983 Aprea Therapeutics, Inc. 3805 OLD EASTON ROAD DOYLESTOWN PA PENNSYLVANIA 18902 215-948-4119 DELAWARE None None Corporation true Oren Gilad 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Executive Officer Director John P. Hamill 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Executive Officer Richard Peters 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Director Jean-Pierre Bizzari 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Director Marc Duey 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Director Michael Grissinger 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Director Gabriela Gruia 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Director John B. Henneman 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Director Rifat Pamukcu 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Director Bernd Seizinger 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Director Biotechnology Decline to Disclose 06b false 2025-12-10 false true true true false 0 Maxim Group LLC 120708 None None 300 Park Avenue 16th Floor New York NY NEW YORK 10022 FL FLORIDA NY NEW YORK true 5783766 3055822 2727944 Includes up to $2,727,943.92 in offering proceeds upon the cash exercise of common stock purchase warrants. false 8 209999 0 In addition to the cash fee, Maxim Group LLC was issued a common stock purchase warrant for the purchase of up to 257,510 shares of common stock as additional compensation. 0 false Aprea Therapeutics, Inc. /s/ Oren Gilad, Ph.D. Oren Gilad, Ph.D. President and CEO 2025-12-23